Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2028, abbreviated as LINC02028, is a non-coding RNA gene in humans that does not encode a protein. As a member of the lincRNA class, it is transcribed as a long RNA (>200 nucleotides) that does not overlap with protein-coding genes. lincRNAs—including LINC02028—are generally thought to regulate gene expression through epigenetic, transcriptional, or post-transcriptional mechanisms, but for most lincRNAs only limited functional and clinical data are available, and no direct roles have been established for LINC02028 in disease, therapy, or as a clinical biomarker. There are currently no drugs known to target this molecule, and it is not considered a classical therapeutic target such as a receptor, enzyme, or transporter.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2028 (LINC02028).